Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Swanson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Contemporary Brachytherapy|January 25, 2013
Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapyCourtney Knaup, Panayiotis Mavroidis, Sotirios Stathakis, et al.
Cureus|December 20, 2021
C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen AblationGarrett L Jensen, Jason Naziri, Kendall P Hammonds, et al.
Technology in Cancer Research & Treatment|December 3, 2019
VMAT Optimization and Dose Calculation in the Presence of Metallic Hip ProsthesesHolly M Parenica, Panayiotis Mavroidis, William Jones, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
Radiobiologically based treatment plan evaluation for prostate seed implantsCourtney Knaup, Panayiotis Mavroidis, Carlos Esquivel, et al.
Medical Physics|July 5, 2012
Investigating the dosimetric and tumor control consequences of prostate seed loss and migrationCourtney Knaup, Panayiotis Mavroidis, Carlos Esquivel, et al.
Clinical Genitourinary Cancer|September 6, 2016
Durability of Artificial Urinary Sphincter With Prior Radiation TherapySameer Jhavar, Gregory Swanson, Niloyjyoti Deb, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate CancerMatthew M Gestaut, Wendi Cai, Shilpa Vyas, et al.
Cancer Genetics and Cytogenetics|December 14, 2004
Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?Arthur R Brothman, Gregory Swanson, Teresa M Maxwell, et al.
The Journal of Urology|January 27, 2009
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
JAMA|November 16, 2006
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Contemporary Brachytherapy|January 25, 2013
Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapyCourtney Knaup, Panayiotis Mavroidis, Sotirios Stathakis, et al.
Cureus|December 20, 2021
C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen AblationGarrett L Jensen, Jason Naziri, Kendall P Hammonds, et al.
Technology in Cancer Research & Treatment|December 3, 2019
VMAT Optimization and Dose Calculation in the Presence of Metallic Hip ProsthesesHolly M Parenica, Panayiotis Mavroidis, William Jones, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
Radiobiologically based treatment plan evaluation for prostate seed implantsCourtney Knaup, Panayiotis Mavroidis, Carlos Esquivel, et al.
Medical Physics|July 5, 2012
Investigating the dosimetric and tumor control consequences of prostate seed loss and migrationCourtney Knaup, Panayiotis Mavroidis, Carlos Esquivel, et al.
Clinical Genitourinary Cancer|September 6, 2016
Durability of Artificial Urinary Sphincter With Prior Radiation TherapySameer Jhavar, Gregory Swanson, Niloyjyoti Deb, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate CancerMatthew M Gestaut, Wendi Cai, Shilpa Vyas, et al.
Cancer Genetics and Cytogenetics|December 14, 2004
Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?Arthur R Brothman, Gregory Swanson, Teresa M Maxwell, et al.
The Journal of Urology|January 27, 2009
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
JAMA|November 16, 2006
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trialIan M Thompson, Catherine M Tangen, Jorge Paradelo, et al.
Pageof 3